These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 29663162)

  • 1. Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis.
    Miao J; Zhu P
    Curr Rheumatol Rep; 2018 Apr; 20(5):30. PubMed ID: 29663162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases.
    Graßhoff H; Comdühr S; Monne LR; Müller A; Lamprecht P; Riemekasten G; Humrich JY
    Front Immunol; 2021; 12():648408. PubMed ID: 33868284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREG-cell therapies for autoimmune rheumatic diseases.
    Miyara M; Ito Y; Sakaguchi S
    Nat Rev Rheumatol; 2014 Sep; 10(9):543-51. PubMed ID: 24980140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ratio of CD147
    Guo H; Xun L; Zhang R; Gou X
    Med Hypotheses; 2018 Jun; 115():1-4. PubMed ID: 29685186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foxp3, Regulatory T Cell, and Autoimmune Diseases.
    Tao JH; Cheng M; Tang JP; Liu Q; Pan F; Li XP
    Inflammation; 2017 Feb; 40(1):328-339. PubMed ID: 27882473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulatory T cells and rheumatic diseases].
    Humrich JY; Kamradt T; Riemekasten G
    Z Rheumatol; 2015 Feb; 74(1):26-32. PubMed ID: 25676125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunction of regulatory T cells in patients with ankylosing spondylitis is associated with a loss of Tim-3.
    Wang M; Liu C; Bond A; Yang J; Zhou X; Wang J; Ji B
    Int Immunopharmacol; 2018 Jun; 59():53-60. PubMed ID: 29625390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function and dysfunction of dendritic cells in autoimmune rheumatic diseases.
    Rutella S; De Cristofaro R; Ferraccioli G
    Hum Immunol; 2009 May; 70(5):360-73. PubMed ID: 19405176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-mediated immune regulation in rheumatic diseases.
    Lam IKY; Chow JX; Lau CS; Chan VSF
    Cancer Lett; 2018 Sep; 431():201-212. PubMed ID: 29859876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional defects in CD4
    Guo H; Zheng M; Zhang K; Yang F; Zhang X; Han Q; Chen ZN; Zhu P
    Sci Rep; 2016 Nov; 6():37559. PubMed ID: 27901054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell subsets and their role in the pathogenesis of rheumatic disease.
    Gizinski AM; Fox DA
    Curr Opin Rheumatol; 2014 Mar; 26(2):204-10. PubMed ID: 24445478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic Therapies for Autoimmune and Connective Tissue Diseases.
    Wolfe RM; Ang DC
    Immunol Allergy Clin North Am; 2017 May; 37(2):283-299. PubMed ID: 28366477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise as a therapeutic tool to counteract inflammation and clinical symptoms in autoimmune rheumatic diseases.
    Perandini LA; de Sá-Pinto AL; Roschel H; Benatti FB; Lima FR; Bonfá E; Gualano B
    Autoimmun Rev; 2012 Dec; 12(2):218-24. PubMed ID: 22776785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell-based immunotherapy of autoimmune diseases.
    Ulivieri C; Baldari CT
    Expert Rev Vaccines; 2013 Mar; 12(3):297-310. PubMed ID: 23496669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
    Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
    Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the role of Interleukin 17 in rheumatologic autoimmune diseases.
    Konya C; Paz Z; Apostolidis SA; Tsokos GC
    Cytokine; 2015 Oct; 75(2):207-15. PubMed ID: 26028353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints.
    Cao D; Börjesson O; Larsson P; Rudin A; Gunnarsson I; Klareskog L; Malmström V; Trollmo C
    Scand J Immunol; 2006 Jun; 63(6):444-52. PubMed ID: 16764698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cell heterogeneity and therapy in autoimmune diseases.
    Zhang R; Miao J; Zhu P
    Autoimmun Rev; 2021 May; 20(5):102715. PubMed ID: 33197573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of regulatory T cells in cellular therapies in autoimmune diseases].
    Boursier G; Siri A; de Boysson H
    Med Sci (Paris); 2012; 28(8-9):757-63. PubMed ID: 22920878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilizing human regulatory T cells for tolerance inducing immunotherapy.
    He X; Koenen HJ; Slaats JH; Joosten I
    Immunotherapy; 2017 Aug; 9(9):735-751. PubMed ID: 28771099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.